Z-2124-2012 Class III Terminated

Recalled by Iris Diagnostics — Chatsworth, CA

FDA device recall Z-2124-2012 was initiated by Iris Diagnostics on Jul 9, 2012 and is designated Class III. Reason for recall: The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive. The recall status is terminated (terminated Jan 27, 2014). Affected quantity: 862.

Recall details

Product Type
Devices
Report Date
Aug 8, 2012
Initiation Date
Jul 9, 2012
Termination Date
Jan 27, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
862

Product description

IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics part number 800-0074. Intended Use: IRISpec CA/CB is an assayed QC material for monitoring of the urine chemistry analytes and devices as listed on the package insert. For in vitro diagnostic (IVD) use only.

Reason for recall

The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.

Distribution pattern

Nationwide Distribution

Code information

Iris Diagnostics part number 800-0074, lot number 131-12.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2124-2012
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Iris Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-2124-2012. Report a data issue: hello@regdatalab.com.